Hamid Hoveyda
Corporate Officer/Principal presso Ogeda SA
Profilo
Hamid Hoveyda is currently the Director-Medical Chemistry at Ogeda SA since 2007.
Previously, he worked as a Principal at Affymax, Inc. and Tranzyme Pharma, Inc. (Canada).
Dr. Hoveyda holds a doctorate degree from the University of British Columbia.
Posizioni attive di Hamid Hoveyda
| Società | Posizione | Inizio |
|---|---|---|
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Corporate Officer/Principal | 01/09/2007 |
Precedenti posizioni note di Hamid Hoveyda
| Società | Posizione | Fine |
|---|---|---|
| Tranzyme Pharma, Inc. (Canada) | Corporate Officer/Principal | - |
| AFFYMAX, INC. | Corporate Officer/Principal | - |
Formazione di Hamid Hoveyda
| University of British Columbia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AFFYMAX, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Health Technology |
| Tranzyme Pharma, Inc. (Canada) |
- Borsa valori
- Insiders
- Hamid Hoveyda
